A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
Clinical trial NCT04853407 · COMPLETED
Trial details
- NCT number
- NCT04853407
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-05
- Primary completion
- 2020-12-24
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.